We’re transforming the industry with clinically validated, AI-powered solutions that help democratize access across the continuum of cardiac care—from screening and diagnosis to treatment and management.
Our FDA-cleared algorithms can detect up to 35 rhythms and morphologies. We’ve developed the world’s first AI-powered, handheld 12-lead ECG system that can detect life-threatening cardiac conditions, including heart attacks, using a reduced lead set and single cable.
Our revolutionary algorithm employs multiple deep neural network AI models to simplify and accelerate the process of gathering and interpreting ECGs for patients and healthcare providers.
Normal Sinus Rhythm
Sinus Rhythm
Atrial Fibrillation
Atrial Flutter
1st Degree AV Block
High degree AV block (including 2nd and 3rd degree AV blocks)
Sinus Arrhythmia
Marked Sinus Arrhythmia
Paced Rhythm
Marked Bradycardia (SR, Bradycardia)
Junctional Rhythm
Sinus Tachycardia (SR, Tachycardia)
Bigeminy
PVCs
Right bundle branch block (RBBB)
Left bundle branch block (LBBB)
Other Intraventricular Block
Left Ventricle Hypertrophy (LVH)
Right Ventricle Hypertrophy (RVH)
Right Atrial Enlargement (RAE)
Left Atrial Enlargement (LAE)
Old Anterior MI
Old Inferior MI
Old Lateral MI
Acute Anterior MI
Acute Inferior MI
Acute Lateral MI
Anterior Ischemia
Inferior Ischemia
Lateral Ischemia
Early Repolarization
Prolonged QT
Paced ECG
Wolff-Parkinson-White (WPW)
Normal ECG
Since 2011, our first-in-class AI-powered cardiac solutions have been making history:
KardiaMobile 6L is the first 6-lead personal ECG and the first to provide remote QT readings.
Kardia AIv2 is the first and only personal ECG algorithm to detect six of the most common arrhythmias, including atrial fibrillation (AFib).
KardiaMobile Card is the only credit card-sized personal ECG cleared by the FDA.
Kardia 12L is the world’s first AI-powered, handheld 12-lead ECG system with a unique single-cable design.
Our technology goes beyond simple data recording, transforming heart health monitoring into meaningful insights. By analyzing ECG and blood pressure data, we identify patterns—such as when arrhythmias are more likely to occur or common triggers—providing personalized guidance. Leveraging generative AI, we detect trends and deliver actionable recommendations, empowering people to take proactive steps in managing their heart health with confidence.
With 24/7 availability, our AI-powered AskKardia virtual assistant provides instant guidance on heart-health recommendations, customer support, and more. Our unique blend of generative AI and rule-based logic delivers health tips, reminders, and educational materials that adapt as your needs change.
Our customized AI solutions streamline and improve access to clinical trials, providing seamless integration, flexibility, advanced data access and reliability.
“While many tech giants focus on general AI, AliveCor has overcome a unique set of challenges developing FDA-cleared AI solutions – validating our technology with extensive clinical evidence, continuously gathering and analyzing data to enhance clinical decision-making and meeting rigorous regulatory standards in the United States, and in countries worldwide.”
Dr. David Albert
Founder and Chief Medical Officer, AliveCor
Research Fellow and AI Team Lead, AliveCor
Let’s transform cardiology together.
Contact our team today.
